Drug Research Co. Inotiv Files Ch. 11 To Cut $325M In Debt
Contract drug research and development company Inotiv Inc. filed a prepackaged Chapter 11 case Wednesday in Texas bankruptcy court with $489 million of debt and support from the majority of its...To view the full article, register now.
Already a subscriber? Click here to view full article